Medindia

X

ResMed Announces Conference Call and Webcast to Discuss Third Quarter 2010 Results

Friday, April 9, 2010 Press Release J E 4
Advertisement


SAN DIEGO, April 8 RESMED INC. (NYSE: RMD), announced today that on Thursday, April 29, 2010, it will release its results for the third quarter and nine months of fiscal year 2010, ended March 31, 2010. A press release with ResMed's results will be issued after 1:00 p.m. Pacific Time and the company will host a conference call and webcast to review its results, market trends, and future outlook.

(Logo: http://www.newscom.com/cgi-bin/prnh/20100203/RESMEDLOGO)

The conference call is scheduled to begin at 1:30 p.m. Pacific Time and will be webcast on ResMed's website at http://investor.resmed.com. Please go to this section of the website 5-10 minutes before the call and click on the icon for the "Q3 2010 results webcast." The online archive of the broadcast will be available approximately 30 minutes after the live call and will continue to be available for two weeks.

International conference call times will be:

TO PARTICIPATE in the conference call, please call one of the numbers below at least 10 minutes before the call begins and identify yourself to the operator:

The replay of the conference call will be available approximately 30 minutes after the call and will be accessible for two weeks at:

ResMed is a leading developer, manufacturer and marketer of products for the screening, treatment and long-term management of sleep-disordered breathing and other respiratory disorders. Further information can be obtained by contacting Connie Bienfait at ResMed Inc. at +1 (858) 836-5971, or by visiting the company's Web site at www.resmed.com.

9:30 p.m. London 6:30 a.m. Sydney, Australia (April 30, 2010)

SOURCE ResMed Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
CTI Receives Complete Response Letter from the FDA...
S
RED BOOK From Thomson Reuters Continues Providing ...